Showing 31 - 40 of 53
Persistent link: https://www.econbiz.de/10012332021
Persistent link: https://www.econbiz.de/10012340995
Persistent link: https://www.econbiz.de/10011718784
Persistent link: https://www.econbiz.de/10011698988
Persistent link: https://www.econbiz.de/10011967315
Persistent link: https://www.econbiz.de/10011780652
Persistent link: https://www.econbiz.de/10012430712
Persistent link: https://www.econbiz.de/10010936969
<Emphasis Type="Bold">Background: The hurdle of cost effectiveness for the selection and reimbursement of drugs in Australia limits access to new medicines based on an assessment of cost relative to clinical benefit. Those drugs that are expensive and provide modest benefits will be less likely to receive a...</emphasis>
Persistent link: https://www.econbiz.de/10011001636